Insights Plug

Breaking

Bitcoin

Blockchain

Finance

Recent Posts

View More

Friday, January 17, 2025

Trade Policy Uncertainty Hasn’t Mattered to Markets


Changing presidential administrations brings policy uncertainty

With a new presidential administration incoming later this month, there’s been a lot of discussion about potential changes to various policies – from tax to trade to regulation – creating some “policy uncertainty.”

Of course, this type of uncertainty is nothing new when administrations change – nor is it specific to the US. That’s why economists have constructed indexes to track policy uncertainty around the world, often incorporating a count of news article mentions of uncertainty for different policies.

Uncertainty indexes can track broad economic policy or a subset like trade policy

There are a couple types of these indexes that are especially relevant currently – broad economic policy uncertainty and narrower trade policy uncertainty.

Going back to 1990, economic policy uncertainty (chart below, blue line) has been the more volatile of the two, typically rising around recessions (grey shaded areas) and falling during expansions (white areas). Right now, it remains close to its historic average (zero line) – as it did in President Trump’s first term (until the pandemic recession).

Trade policy uncertainty (purple line), however, saw comparatively mild fluctuations from 1990 until the first Trump administration, when it increased as President Trump reintroduced tariffs. And since the latest election, we’ve seen trade policy uncertainty rise back to the highs last seen in President Trump’s first term.



History shows markets react to economic policy uncertainty, not trade policy uncertainty

Since there’s the old Wall Street saying that “markets hate uncertainty,” you might think this increase in trade policy uncertainty would be bad for markets.

Yet, when you overlay the VIX equity volatility metric (chart below, orange line) with trade policy uncertainty, you can see there’s no real relationship.

Policy uncertainty

When trade policy uncertainty hit historic highs in 2018, 2019, and now, the VIX typically stayed below its average since 1990 (indicated by negative numbers in chart). Not to mention that the S&P 500 and Nasdaq-100 have each hit 10 new record highs since election day.

But the chart does show that markets hate economic policy uncertainty.

When we see jumps in economic policy uncertainty, we also see jumps in the VIX. And when we see above-average economic policy uncertainty (positive numbers), we also usually see above-average VIX readings (positive numbers).

Of course, these spikes and above-average readings go hand-in-hand with recessions, which naturally create uncertainty about how economic policy should respond (especially since last two recessions were historically bad) and drive market selloffs.

Narrower scope of trade policy limits its impact on markets

This gets at the main difference between economic policy and trade policy. Economic policy is broad, while trade policy is narrow, making it less important to the overall health of the economy.

So, if history is a guide, when uncertainty is limited to trade policy, the impact on markets also tends to be limited.

The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither Nasdaq, Inc. nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies or Nasdaq proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED. © 2024. Nasdaq, Inc. All Rights Reserved.



from Finance – Techyrack Hub https://ift.tt/rR8SW5G
via IFTTT

Bitcoin’s Bull Market Isn’t Over Yet! (here’s why) – Bitcoin Price Prediction Today



Bitcoin News Today – Bitcoin’s Bull Market Isn’t Over Yet! (here’s why) – Bitcoin Price Prediction Today // Cryptocurrency News Today // Crypto News Today

🥇 GET $500 FREE TRADE:
– Click the link and register
– Claim your $500 free trade

🥈 Toobit: NO KYC
– Click the link and register
– Claim $30’210 free bonus

▶ CRYPTO TECHNICAL ANALYSIS PLATFORM
TradingLite: VOLUME ANALYSIS
TradingView: TECHNICAL ANALYSIS

▶ SOCIAL MEDIA
Twitter:
Discord:

▶ TIMESTAMPS
0:00 Bitcoin Price Prediction

▶ DONATIONS
Bitcoin (BTC): 15ViBpKAhNCPzY9UXc6KoTEabUqTEXo1Hr
Ethereum (ETH): 0x2aA9a238511d267662A951E87C36eAd3a0275006
Bitcoin Cash (BCH): qztzh024tfg7fdk4s04hr2ggdw7v9m9kdqmavmarjj

▶ TOPICS
Bitcoin Price Prediction 2024, BTC Price Prediction 2024
Bitcoin News Today, Bitcoin Analysis, Bitcoin Price Analysis, Bitcoin Live
Bitcoin Trading Strategy, Bitcoin Technical Analysis
Crypto News Today, Cryptocurrency News Today
Daily Crypto Technical Analysis
Daily Crypto Price Prediction Today
Daily Crypto Trading, Crypto Live
Daily Cryptocurrency Technical Analysis
Daily Cryptocurrency Trading News
Daily Cryptocurrency Trading Strategy

▶ DISCLAIMER
Video is for general information purposes only and not investment, legal, tax or financial advice. This video is purely opinion of the speaker who is not a licensed financial advisor or a registered investment advisor. Purchasing cryptocurrencies or cryptocurrency market in general is risky. The speaker does not guarantee any particular outcome.

▶ MUSIC
Nature Healing Society:

This video relates to the following:
btc, btc price prediction 2024, btc price prediction, btc price prediction today, btc technical analysis, btc technical analysis today, btc price analysis, btc price analysis today, btc news today, btc news today 2024, btc analysis, btc analysis today, btc prediction, btc prediction today, btc trading strategy 2024, bitcoin, bitcoin price prediction 2024, bitcoin price prediction today, bitcoin technical analysis today, bitcoin price analysis, bitcoin price analysis today, bitcoin news today, bitcoin news today 2024, bitcoin analysis, bitcoin analysis today, bitcoin prediction, bitcoin prediction today, bitcoin trading strategy 2024, cryptocurrency, cryptocurrency news today, cryptocurrency trading, cryptocurrency trading strategy, cryptocurrency technical analysis, cryptocurrency price prediction, crypto, crypto news today, crypto technical analysis, crypto price prediction

#bitcoin #BTC #cryptocurrency​

source



from Bitcoin – Techyrack Hub https://ift.tt/zoX0TBE
via IFTTT

Fed's rate cut timing is right: Strategist



For the first time in more than four years, the Federal Reserve has cut the target for its benchmark interest rate, slashing it by 50 basis points. Morgan Stanley Asset Management Co-Head of Broad Markets Fixed Income Vishal Khanduja notes that, based on the Fed’s projections, unemployment is now in focus rather than inflation. Khanduja describes the new rate-cutting cycle as a “recalibration” rather than one prompted by recession fears. He also thinks the US economy is still on track for a soft landing, arguing that “The timing [of cuts] is right. Maybe they’re off by a meeting or two, but they have a lot in their toolkit.” Watch the video above for Khanduja’s takeaways for bond market investors. For more expert insight and the latest market action, click here to watch this full episode of Market Domination.
#youtube #stockmarket #news

About Yahoo Finance:

Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life.

– Get the latest news and data at finance.yahoo.com

– Download the Yahoo Finance app on Apple ( or Android (

– Follow Yahoo Finance on social:

X:
Instagram:
TikTok:
Facebook:
LinkedIn:

source



from Finance – Techyrack Hub https://ift.tt/vTZNlzL
via IFTTT

US Bitcoin reserve has pundits in tailspin as Trump inauguration looms


Trump’s term may witness the adoption of a US Bitcoin reserve. Is this the only way forward or a rather large nail in the dollar’s coffin?



from Blockchain – Techyrack Hub https://ift.tt/7VGRdei
via IFTTT

Thursday, January 16, 2025

Why Experts Are Predicting 15X Returns for This Innovative Blockchain Project – Analytics Insight



Why Experts Are Predicting 15X Returns for This Innovative Blockchain Project  Analytics Insight



from Blockchain – Techyrack Hub https://ift.tt/68nkVag
via IFTTT

Duke Energy CEO Lynn Good’s advice to her younger self



© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.



from Finance – Techyrack Hub https://ift.tt/rtd8jmc
via IFTTT

Johnson & Johnson (JNJ) likely to report mixed results for Q4 2024


Johnson & Johnson (NYSE: JNJ) is set to publish its December-quarter report on January 22, amid expectations for mixed results. The company, which has faced both challenges and tailwinds in recent years, is betting on its extensive drug pipeline and product launches to drive growth beyond 2025.

Last year, the healthcare giant’s stock experienced high volatility, marked by a series of ups and downs. The stock’s last closing price broadly matches JNJ’s value nearly four years ago. However, the company has been rewarding shareholders with regular dividend hikes over the past several years. It currently offers a yield of 3.4%, which is well above the S&P 500 average.

Q4 Report Due

Johnson & Johnson is expected to report fourth-quarter results on Wednesday, January 22, at 6:20 am ET. Wall Street analysts have forecast a 5% increase in revenues to $22.45 billion in Q4. However, the company’s adjusted profit is expected to decline to $2.04 per share in the final months of the fiscal year from $2.29 per share in Q4 2023.

From Johnson & Johnson’s Q3 2024 earnings call:

“Our performance once again reflects the unique breadth of our business and our commitment to delivering the next wave of healthcare innovation to patients around the world. It also reflects the work we have done to shift our pipeline and portfolio to high-innovation and high-growth markets. That work continues, which you saw with the recently completed acquisitions of Shockwave and V-Wave in med tech and Ambrx, Proteologix, and the NM26 bispecific antibody in innovative medicine.”

Last year, stable sales performance in the US and Europe outweighed weakness in Asian markets like China and Japan amid the economic slowdown. At the same time, healthy cash flows have enabled the drugmaker to increase research and development expenses, spending $5 billion in the third quarter alone. However, ongoing legal disputes over product safety and related settlements will remain a drag on the company’s finances in the near future.

Results Beat

Johnson & Johnson has consistently beaten Wall Street’s quarterly earnings estimates for over a decade. In the most recent quarter, both revenue and profit topped expectations. Third-quarter sales rose 5% annually to $22.5 billion, with the Innovative Medicine and MedTech business segments growing 5% and 6% respectively.

Meanwhile, adjusted earnings decreased by 9% year-over-year to $2.42 per share. For the whole of FY24, the company expects sales to be in the range of $88.4 billion to $88.8 billion, and adjusted earnings between $9.88 per share and $9.98 per share. On a reported basis, net income declined in double digits to $2.7 billion or $1.11 per share.

In Growth Mode

This week, the company announced the acquisition of Intra-Cellular Therapies, a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system disorders, for around $14.6 billion. The deal follows a series of acquisitions the company carried out recently, including heart device maker Shockwave Medical and V-Wave, which develops treatments for heart failure.

JNJ has been languishing below its 52-week average price for more than a month. The stock traded lower in early trading on Wednesday.



from NYSE Updates – Techyrack Hub https://ift.tt/mJdNT4r
via IFTTT

Comments system

[blogger][disqus][facebook]

Disqus Shortname

sigma2